Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Highmark / Rydapt Midostaurin

Rydapt Midostaurin — Highmark

4 indications indexed for this drug.

Aggressive Systemic Mastocytosis Asm
View coverage criteria
Mast Cell Leukemia Mcl
View coverage criteria
Newly Diagnosed Acute Myeloid Leukemia Aml
View coverage criteria
Systemic Mastocytosis With Associated Hematological Neoplasm
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.